HSD17B2
Basic information
Region (hg38): 16:82035004-82098534
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (72 variants)
- not_provided (9 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSD17B2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002153.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 66 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 66 | 8 | 7 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSD17B2 | protein_coding | protein_coding | ENST00000199936 | 5 | 63531 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.85e-10 | 0.0346 | 125541 | 0 | 207 | 125748 | 0.000823 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.57 | 279 | 214 | 1.30 | 0.0000113 | 2500 |
Missense in Polyphen | 89 | 69.93 | 1.2727 | 815 | ||
Synonymous | -2.89 | 126 | 90.9 | 1.39 | 0.00000534 | 772 |
Loss of Function | -0.436 | 14 | 12.3 | 1.13 | 6.05e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000691 | 0.000691 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00268 | 0.00268 |
European (Non-Finnish) | 0.00106 | 0.00106 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00115 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3 uses NADPH.;
- Pathway
- Steroid hormone biosynthesis - Homo sapiens (human);Ovarian steroidogenesis - Homo sapiens (human);Androgen Receptor Network in Prostate Cancer;Vitamin D Receptor Pathway;Steroid Biosynthesis;Metabolism of lipids;Androgen and estrogen biosynthesis and metabolism;Metabolism;Estrogen biosynthesis;Metabolism of steroid hormones;Metabolism of steroids;C21-steroid hormone biosynthesis and metabolism;Steroid hormones
(Consensus)
Intolerance Scores
- loftool
- 0.326
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.36
Haploinsufficiency Scores
- pHI
- 0.203
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.417
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.915
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hsd17b2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- in utero embryonic development;placenta development;estrogen biosynthetic process;response to retinoic acid;oxidation-reduction process
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- estradiol 17-beta-dehydrogenase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;testosterone dehydrogenase (NAD+) activity